Table 3. Association between a first-degree FHD and the serum A-FABP levels.

A-FABP	Men			Premenopausal women			Postmenopausal women
	OR	95% CI	P	OR	95% CI	P	OR	95% CI	P
Unadjusted	1.184	1.075–1.303	0.001	1.128	1.052–1.209	0.001	1.155	1.072–1.244	<0.001
Adjusted for BMI	1.159	1.043–1.288	0.006	1.113	1.030–1.203	0.007	1.138	1.050–1.232	0.002
Adjusted for VFA	1.147	1.034–1.273	0.010	1.097	1.019–1.182	0.014	1.135	1.048–1.230	0.002
Adjusted for SFA	1.165	1.050–1.292	0.004	1.115	1.036–1.200	0.004	1.151	1.066–1.243	<0.001
Adjusted for HOMA-IR	1.122	1.012–1.243	0.029	1.116	1.039–1.199	0.003	1.134	1.049–1.226	0.002
Full model	1.134	1.013–1.270	0.029	1.092	1.006–1.185	0.036	1.125	1.032–1.227	0.008

Abbreviations: A-FABP, adipokine adipocyte fatty acid binding protein; BMI, body mass index; FHD, family history of diabetes; HOMA-IR, homeostasis model assessment-insulin resistance; SFA, subcutaneous fat area; VFA, visceral fat area.

Full model included age, BMI, W, VFA, SFA, SBP, DBP, HbA1c, HOMA-IR, HOMA-β, TG, HDL-c, LDL-c and CRP.